Exchange: NASDAQ·Updated 05:40 PM EST

CELU News

News
all
press releases
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual Peptide APIs Manufactured in the United States
Celularity Inc. (Nasdaq: CELU) (Celularity), a longevity-focused regenerative and cellular medicine company, and Vesalius Longevity Labs Inc. (Vesalius), a leading, global peptide and longevity brand, today announced that they have entered into an exclusive manufacturing agreement to establish a...
Business Wire
Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual Peptide APIs Manufactured in the United States
Celularity Inc. (Nasdaq: CELU) (Celularity), a longevity-focused regenerative and cellular medicine company, and Vesalius Longevity Labs Inc. (Vesalius), a leading, global peptide and longevity brand, today announced that they have entered into an exclusive manufacturing agreement to establish a...
Business Wire
More News
Celularity (CELU) stock surged 131% following a $300M U.S. manufacturing collaboration with MuseCell Innovations in New Jersey.read more...
Benzinga
Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regular session. The company's market cap stands at $25.0 million. Propanc Biopharma (NASDAQ:PPCB) stock increased byread more...
Benzinga
The market is getting a fresh reminder that the biggest opportunities are increasingly being built around AI, cybersecurity, advanced medicine and the infrastructure required to commercialize them. Propanc Biopharma (NASDAQ:PPCB), Celularity (NASDAQ:CELU), NeOnc Technologies (NASDAQ:NTHI), Salesforce (NYSE:CRM), CrowdStrike (NASDAQ:CRWD), and Okta (NASDAQ:OKTA).
24-7 Market News
Celularity (NASDAQ:CELU) may have just added a potentially significant new dimension to its cellular-medicine story: manufacturing revenue from a third-party regenerative-medicine platform.
24-7 Market News
Celularity Inc. (Nasdaq: CELU) (Celularity), a longevity-focused regenerative and cellular medicine company, and MuseCell Innovations Pte. Ltd. (MCI), the owner of the Dezawa MuseCell platform, today announced an additional U.S.-based manufacturing collaboration under which Celularity will...
Business Wire
Celularity (NASDAQ:CELU) Stock Price Up 0.4% - Here's Why...
MarketBeat

Advertisement|Remove ads.